금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Nasdaq, S&P end lower as tech stocks fall
STORY: U.S. stocks ended mixed on Wednesday, with the Dow gaining just over a third of a percent, wh...
Japanese Yen sinks even after the BoJ hikes
USD/JPY spent Wednesday grinding higher again, which by rights should not be happening. The Bank of ...
Morgan Stanley Direct Lending targets Capstone JV scaling to ~$700M in assets over 4 to 6 quarters
Dow Jones Futures: Market At Highs With Iran, Trump-Xi Summit In Focus; Apple, Nvidia, Boeing In Buy Areas
Dow Jones futures: The stock market hit fresh highs this past week with U.S.-Iran news and the Trump-Xi summit in focus. Apple, Nvidia, Boeing are in buy areas.
S&P 500 records weekly gains following strong jobs report, defying geopolitical jitters
Chartwell Retirement Residences reports Q1 results
Explosion, fire reported at PBF Energy's Chalmette, Louisiana, refinery
MP Materials Stock Popped Then Dropped. 2 Reasons Its Rare Earths Earnings Wowed Markets.
Thursday, MP reported first-quarter earnings per share of 3 cents from sales of $90.6 million. Wall Street was looking for a loss of 3 cents from sales of closer to $75 million.
Global stocks diverge, oil rises as fresh US-Iran clashes hit peace hopes
Global stock markets diverged and oil prices rose Friday as fresh US-Iran clashes in the Strait of Hormuz jolted hopes for a deal to end the Middle East war and reopen the crucial waterway.But US cons ...
US Equity Indexes Advance This Week as AI-Trade Boosts Technology While Iran Ceasefire Continues
US equity indexes rose this week as quarterly earnings showed the benign effect of artificial intell
‘The S&P 500 seems to be doing particularly well’: I’m 66. Is this a good time to invest $100,000 in the stock market?
“I own my home and I have no debt.”
Is This the Right Time to Rebalance Your Portfolio?
There's no perfect time to rebalance your portfolio. But there might be a right time for you. Maybe it's right now, and maybe it's not.
Pason Systems GAAP EPS of $0.17, revenue of $102.4M beats by $27.68M
Inhibrx rises on upcoming interim mid-stage data for head and neck cancer asset